EDAVAMADAM & CO LTD
Company number 12462974 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
EDAVAMADAM & CO LTD - Analysis Report
Company Number: 12462974
Analysis Date: 2025-07-20 16:17 UTC
Financial Health Assessment Report for EDAVAMADAM & CO LTD (as at 29 February 2024)
1. Financial Health Score: B
Explanation:
The company exhibits a sound financial position with improving working capital and positive shareholder equity. The steady growth in net current assets and shareholders' funds over the past years indicates healthy operations and prudent management of liabilities. However, the company operates on a modest scale (Micro entity), with a very low fixed asset base, and has a relatively high director's loan balance, which necessitates monitoring. Overall, the financial "vital signs" suggest a generally healthy condition with some areas for caution.
2. Key Vital Signs
| Metric | 2024 Value (£) | Interpretation |
|---|---|---|
| Fixed Assets | 2,000 | Very low long-term asset investment; typical for a service-based micro entity. |
| Current Assets | 58,128 | Healthy level of current assets, indicating available resources to meet short-term obligations. |
| Current Liabilities | 30,626 | Moderate current liabilities; manageable relative to current assets. |
| Net Current Assets | 27,502 | Positive working capital, showing liquidity strength ("healthy cash flow"). |
| Total Assets Less Current Liabilities | 29,502 | Indicates company's net asset value after covering short-term debts. |
| Shareholders' Funds | 29,502 | Solid equity base; increasing year-on-year, showing retained profits or capital injections. |
| Director's Loan Account | 28,422 | High amount owed to the director; common in small companies but requires transparency and control. |
Trend Analysis:
- Net current assets have increased steadily from negative (£6,702) in 2020 to £27,502 in 2024, reflecting improved liquidity and operational efficiency.
- Shareholders’ funds grew from £1,298 in 2020 to £29,502 in 2024, indicating capital growth or accumulated profits.
- Fixed assets have decreased from £8,000 in 2020 to £2,000 in 2024, suggesting limited investment in long-term assets, consistent with the company's specialist medical practice classification.
3. Diagnosis: What the Financial Data Reveals
The company presents with strong liquidity and solvency indicators for a micro-sized specialist medical practice. The steadily improving net current assets signify a "healthy cash flow," which is critical for meeting short-term obligations without financial strain. The positive and growing shareholders' funds reflect capital stability and suggest that the business is not reliant on external debt for its operations.
However, the relatively high director's loan balance (£28,422) is a "symptom of internal financing," which, while common in small companies, should be carefully managed to avoid potential cash flow risks or governance issues. The low fixed asset base indicates minimal investment in physical or intangible assets, which is typical for this business type but could limit growth capacity.
The company has complied with filing deadlines, with no overdue accounts or confirmation statements, indicating good administrative health.
4. Recommendations: Actions to Improve Financial Wellness
Monitor Director's Loan Account:
- Regularly review and formalize terms of director's advances to ensure transparency and avoid liquidity strain. Consider repaying or converting this loan into equity if appropriate.
Strengthen Asset Base:
- Evaluate opportunities to invest strategically in essential fixed assets or technology to enhance service delivery and support sustainable growth.
Cash Flow Management:
- Maintain current positive working capital levels by careful management of receivables and payables. Implement budgeting and forecasting to anticipate cash needs.
Profitability Insight:
- Although profit and loss data are not publicly filed, internally tracking profitability metrics is essential to diagnose operational efficiency and future sustainability.
Governance and Compliance:
- Continue timely filing and compliance to maintain good standing. Consider appointing additional directors or advisors to support governance structure as the company grows.
Growth and Diversification:
- Explore potential for expanding services or geographic reach cautiously, ensuring financial resources are adequate to support growth without jeopardizing liquidity.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.